Form 4: Inari Medical Director Dana G. Mead, Jr. Reports Stock Transactions
SEC Form 4 Filing
Director Dana G. Mead, Jr. of Inari Medical, Inc. reports acquisition of restricted stock units and disposal of common stock.
Summary
- On April 24, 2024, Dana G. Mead, Jr., a director of Inari Medical, Inc., acquired 4,126 shares of common stock in the form of restricted stock units at a price of $42.41 per share.
- On the same day, Mead disposed of 11,148 shares of common stock.
- Following these transactions, Mead directly owns 11,148 shares of Inari Medical, Inc.
Sentiment
Score: 5
Explanation: This is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key individuals within the company.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 04/24/2024 | Date of stock acquisition and disposal by Dana G. Mead, Jr. |
| 04/26/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.